HTStec's Phenotypic Drug Discovery Trends 2013 report was published on 20 March 2013. This 59 page market report summarizes the results of HTStec's industry-wide global web-based benchmarking survey on phenotypic drug discovery (PDD) carried out in March 2013. The survey was initiated by HTStec as part of its tracking of this emerging life science marketplace. The questionnaire was compiled by HTStec with the assistance KOLs in the field and attempts to meet the needs, requirements and interests of vendors hoping to address this space. The objective was to understand current thinking, attitudes and approaches towards PDD and future requirements for the implementation of phenotypic primary screening. Survey respondents were drawn from persons or groups undertaking PDD and phenotypic primary screening. In addition feedback was obtained from those currently interested in PPD and considering future investigation in this area. The report is based on 102 responses from Pharma, Biotech and University Labs, mainly in Europe and North America.